• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人羊膜间充质干细胞来源的外泌体通过 miR-369-3p/YAF2/PDCD5/p53 通路抑制卵巢颗粒细胞凋亡。

Human Amniotic Fluid Mesenchymal Stem Cell-Derived Exosomes Inhibit Apoptosis in Ovarian Granulosa Cell via miR-369-3p/YAF2/PDCD5/p53 Pathway.

机构信息

Department of Acupuncture and Moxibustion, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200086, China.

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

出版信息

Oxid Med Cell Longev. 2022 Jul 26;2022:3695848. doi: 10.1155/2022/3695848. eCollection 2022.

DOI:10.1155/2022/3695848
PMID:35936223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9346541/
Abstract

Human amniotic fluid stem cell-derived exosome (HuAFSC-exosome) transplantation is considered a promising treatment for premature ovarian failure (POF). However, its mechanism remains unclear. In this study, exosomes were isolated and enriched from HuAFSC subsets of CD44+/CD105+, and the exosomes were transplanted into a POF model and . Our results confirmed that the exosomes produced by CD44+/CD105+ HuAFSCs could achieve therapeutic effects in a mouse POF model. Our research also showed that CD44+/CD105+ HuAFSC-exosomes carrying miR-369-3p could specifically downregulate the expression of YAF2, inhibit the stability of PDCD5/p53, and reduce the apoptosis of ovarian granulosa cells (OGCs), thereby exerting therapeutic effects on POF. Knowledge of these mechanisms demonstrates that miRNAs carried by CD44+/CD105+ HuAFSC-exosomes are critical to the therapy of POF. This will be useful for the clinical application of stem cells.

摘要

人羊膜间充质干细胞来源的外泌体(HuAFSC-exosome)移植被认为是治疗卵巢早衰(POF)的一种有前途的方法。然而,其机制尚不清楚。在这项研究中,从 HuAFSC 亚群 CD44+/CD105+中分离和富集外泌体,并将外泌体移植到 POF 模型中。我们的结果证实,CD44+/CD105+ HuAFSC 产生的外泌体可以在小鼠 POF 模型中发挥治疗作用。我们的研究还表明,携带 miR-369-3p 的 CD44+/CD105+ HuAFSC-exosomes 可以特异性地下调 YAF2 的表达,抑制 PDCD5/p53 的稳定性,减少卵巢颗粒细胞(OGCs)的凋亡,从而对 POF 发挥治疗作用。对这些机制的认识表明,CD44+/CD105+ HuAFSC-exosomes 携带的 miRNAs 对 POF 的治疗至关重要。这将有助于干细胞的临床应用。

相似文献

1
Human Amniotic Fluid Mesenchymal Stem Cell-Derived Exosomes Inhibit Apoptosis in Ovarian Granulosa Cell via miR-369-3p/YAF2/PDCD5/p53 Pathway.人羊膜间充质干细胞来源的外泌体通过 miR-369-3p/YAF2/PDCD5/p53 通路抑制卵巢颗粒细胞凋亡。
Oxid Med Cell Longev. 2022 Jul 26;2022:3695848. doi: 10.1155/2022/3695848. eCollection 2022.
2
miR-126-3p containing exosomes derived from human umbilical cord mesenchymal stem cells promote angiogenesis and attenuate ovarian granulosa cell apoptosis in a preclinical rat model of premature ovarian failure.来源于人脐带间充质干细胞的含有 miR-126-3p 的外泌体可促进血管生成并减轻早发性卵巢功能衰竭的临床前大鼠模型中的卵巢颗粒细胞凋亡。
Stem Cell Res Ther. 2022 Jul 26;13(1):352. doi: 10.1186/s13287-022-03056-y.
3
miR-644-5p carried by bone mesenchymal stem cell-derived exosomes targets regulation of p53 to inhibit ovarian granulosa cell apoptosis.骨间充质干细胞来源的外泌体携带的 miR-644-5p 通过靶向调节 p53 抑制卵巢颗粒细胞凋亡。
Stem Cell Res Ther. 2019 Nov 29;10(1):360. doi: 10.1186/s13287-019-1442-3.
4
MicroRNA-22-3p in human umbilical cord mesenchymal stem cell-secreted exosomes inhibits granulosa cell apoptosis by targeting KLF6 and ATF4-ATF3-CHOP pathway in POF mice.人脐带间充质干细胞分泌的外泌体中的 microRNA-22-3p 通过靶向 KLF6 和 ATF4-ATF3-CHOP 通路抑制 POF 小鼠颗粒细胞凋亡。
Apoptosis. 2023 Aug;28(7-8):997-1011. doi: 10.1007/s10495-023-01833-5. Epub 2023 Mar 31.
5
Improving Granulosa Cell Function in Premature Ovarian Failure with Umbilical Cord Mesenchymal Stromal Cell Exosome-Derived hsa_circ_0002021.脐带间充质干细胞外泌体源性 hsa_circ_0002021 改善卵巢早衰颗粒细胞功能。
Tissue Eng Regen Med. 2024 Aug;21(6):897-914. doi: 10.1007/s13770-024-00652-2. Epub 2024 Jun 6.
6
CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure.CD44+/CD105+ 人羊水间充质干细胞在化疗诱导的卵巢早衰小鼠模型中可在卵巢中长期存活和增殖。
Int J Med Sci. 2012;9(7):592-602. doi: 10.7150/ijms.4841. Epub 2012 Sep 11.
7
HucMSCs-exosomes containing miR-21 promoted estrogen production in ovarian granulosa cells via LATS1-mediated phosphorylation of LOXL2 and YAP.外泌体包裹 miR-21 的 HucMSCs 通过 LATS1 介导的 LOXL2 和 YAP 磷酸化促进卵巢颗粒细胞中雌激素的产生。
Gen Comp Endocrinol. 2022 Jun 1;321-322:114015. doi: 10.1016/j.ygcen.2022.114015. Epub 2022 Mar 7.
8
Exosomal miRNA-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating SIRT7.人脐带间充质干细胞来源的外泌体 miR-17-5p 通过调控 SIRT7 改善卵巢早衰患者卵巢功能
Stem Cells. 2020 Sep;38(9):1137-1148. doi: 10.1002/stem.3204. Epub 2020 May 29.
9
Plasma-derived exosome miR-10a-5p promotes premature ovarian failure by target BDNF via the TrkB/Akt/mTOR signaling pathway.血浆衍生的外泌体 miR-10a-5p 通过 TrkB/Akt/mTOR 信号通路靶向 BDNF 促进卵巢早衰。
Int J Biol Macromol. 2024 Oct;277(Pt 1):134195. doi: 10.1016/j.ijbiomac.2024.134195. Epub 2024 Jul 26.
10
Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying MicroRNA-29a Improves Ovarian Function of Mice with Primary Ovarian Insufficiency by Targeting HMG-Box Transcription Factor/Wnt/-Catenin Signaling.人脐带间充质干细胞来源的细胞外囊泡携带 microRNA-29a 通过靶向 HMG-Box 转录因子/Wnt/-Catenin 信号通路改善原发性卵巢功能不全小鼠的卵巢功能。
Dis Markers. 2022 Jul 2;2022:5045873. doi: 10.1155/2022/5045873. eCollection 2022.

引用本文的文献

1
Precision medicine in premature ovarian insufficiency: a focus on the precision therapeutic strategies for mesenchymal stem cells.精准医学在卵巢早衰中的应用:聚焦间充质干细胞的精准治疗策略
Stem Cell Res Ther. 2025 Jul 16;16(1):381. doi: 10.1186/s13287-025-04512-1.
2
Characteristic analysis of N-methyladenine in different parts of yak epididymis.牦牛附睾不同部位N-甲基腺嘌呤的特征分析
BMC Genomics. 2025 May 19;26(1):500. doi: 10.1186/s12864-025-11684-w.
3
The revolutionary role of placental derivatives in biomedical research.

本文引用的文献

1
Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake.外泌体:大规模生产、分离、药物加载效率、生物分布和摄取。
J Control Release. 2022 Jul;347:533-543. doi: 10.1016/j.jconrel.2022.05.027. Epub 2022 May 24.
2
Extracellular Vesicles Protect the Neonatal Lung from Hyperoxic Injury through the Epigenetic and Transcriptomic Reprogramming of Myeloid Cells.细胞外囊泡通过对髓样细胞的表观遗传和转录组重编程来保护新生肺免于高氧损伤。
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1418-1432. doi: 10.1164/rccm.202102-0329OC.
3
Bone marrow mesenchymal stem cell-derived exosomal miR-34c-5p ameliorates RIF by inhibiting the core fucosylation of multiple proteins.
胎盘衍生物在生物医学研究中的革命性作用。
Bioact Mater. 2025 Mar 19;49:456-485. doi: 10.1016/j.bioactmat.2025.03.011. eCollection 2025 Jul.
4
Non-coding RNA-mediated granulosa cell dysfunction during ovarian aging: From mechanisms to potential interventions.非编码RNA介导的卵巢衰老过程中的颗粒细胞功能障碍:从机制到潜在干预措施。
Noncoding RNA Res. 2025 Mar 3;12:102-115. doi: 10.1016/j.ncrna.2025.03.001. eCollection 2025 Jun.
5
Application of adult stem cells in obstetrics and gynecology: A scoping review.成体干细胞在妇产科中的应用:一项范围综述。
Eur J Obstet Gynecol Reprod Biol X. 2025 Jan 22;25:100367. doi: 10.1016/j.eurox.2025.100367. eCollection 2025 Mar.
6
Mesenchymal stem cell-derived extracellular vesicles for human diseases.间充质干细胞衍生的细胞外囊泡用于人类疾病治疗
Extracell Vesicles Circ Nucl Acids. 2024 Feb 6;5(1):64-82. doi: 10.20517/evcna.2023.47. eCollection 2024.
7
Novel Advances in Cell-Free Therapy for Premature Ovarian Failure (POF): A Comprehensive Review.卵巢早衰(POF)无细胞疗法的新进展:综述
Adv Pharm Bull. 2024 Oct;14(3):543-557. doi: 10.34172/apb.2024.059. Epub 2024 Jul 31.
8
Mesenchymal stem cell-derived extracellular vesicles therapy for primary ovarian insufficiency: a systematic review and meta-analysis of pre-clinical studies.间充质干细胞衍生的细胞外囊泡治疗原发性卵巢功能不全:临床前研究的系统评价和荟萃分析。
J Ovarian Res. 2024 Oct 14;17(1):200. doi: 10.1186/s13048-024-01513-1.
9
Histological assessment for investigation of dose-dependent ovarian toxicity of cyclophosphamide in the rat.环磷酰胺对大鼠卵巢剂量依赖性毒性研究的组织学评估
Heliyon. 2024 Aug 22;10(17):e36767. doi: 10.1016/j.heliyon.2024.e36767. eCollection 2024 Sep 15.
10
Stem cell-derived extracellular vesicles in premature ovarian failure: an up-to-date meta-analysis of animal studies.干细胞衍生的细胞外囊泡在卵巢早衰中的作用:动物研究的最新荟萃分析。
J Ovarian Res. 2024 Sep 9;17(1):182. doi: 10.1186/s13048-024-01489-y.
骨髓间充质干细胞来源的外泌体 miR-34c-5p 通过抑制多种蛋白质的核心岩藻糖基化改善 RIF。
Mol Ther. 2022 Feb 2;30(2):763-781. doi: 10.1016/j.ymthe.2021.10.012. Epub 2021 Oct 19.
4
Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta-analysis.间质基质细胞细胞外囊泡治疗急性和慢性呼吸疾病:一项荟萃分析。
J Extracell Vesicles. 2021 Oct;10(12):e12141. doi: 10.1002/jev2.12141.
5
Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure.人脐带间充质干细胞移植治疗卵巢早衰。
Stem Cell Res Ther. 2021 Aug 11;12(1):454. doi: 10.1186/s13287-021-02529-w.
6
Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease Treatment.干细胞衍生的外泌体:一种治疗神经退行性疾病的新策略。
Mol Neurobiol. 2021 Jul;58(7):3494-3514. doi: 10.1007/s12035-021-02324-x. Epub 2021 Mar 21.
7
Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities.人骨髓间充质干细胞治疗卵巢早衰:新的挑战和机遇。
Stem Cell Res Ther. 2021 Mar 3;12(1):161. doi: 10.1186/s13287-021-02212-0.
8
MicroRNA-146b-5p overexpression attenuates premature ovarian failure in mice by inhibiting the Dab2ip/Ask1/p38-Mapk pathway and γH2A.X phosphorylation.miRNA-146b-5p 过表达通过抑制 Dab2ip/Ask1/p38-Mapk 通路和 γH2A.X 磷酸化来减轻小鼠卵巢早衰。
Cell Prolif. 2021 Jan;54(1):e12954. doi: 10.1111/cpr.12954. Epub 2020 Nov 9.
9
Amniotic fluid mesenchymal stem cells repair mouse corneal cold injury by promoting mRNA N4-acetylcytidine modification and ETV4/JUN/CCND2 signal axis activation.羊水间充质干细胞通过促进mRNA N4-乙酰胞苷修饰和ETV4/JUN/CCND2信号轴激活来修复小鼠角膜冷损伤。
Hum Cell. 2021 Jan;34(1):86-98. doi: 10.1007/s13577-020-00442-7. Epub 2020 Oct 3.
10
Dimethyloxaloylglycine-stimulated human bone marrow mesenchymal stem cell-derived exosomes enhance bone regeneration through angiogenesis by targeting the AKT/mTOR pathway.二甲基草酰甘氨酸刺激的人骨髓间充质干细胞衍生的外泌体通过靶向 AKT/mTOR 通路促进血管生成增强骨再生。
Stem Cell Res Ther. 2019 Nov 20;10(1):335. doi: 10.1186/s13287-019-1410-y.